Vericel® Burn Care

About Vericel® Burn Care

NEXOBRID® (anacaulase-bcdb) is indicated for eschar removal in adults and pediatric patients w/ deep partial and/or full thickness thermal burns. Contraindicated in patients w/ hypersensitivity to anacaulase-bcdb, bromelain, pineapples, papayas or papain. The most common adverse reactions (>5%) in adults were pruritus, pyrexia, wound complication, anemia, vomiting and insomnia. The most common adverse reactions (>5%) in pediatric patients were pruritus, pyrexia and vomiting. See Full Indication, including Limitations of Use, and Important Safety Information and Full Prescribing Info: bit.ly/ISIPI. PRIVACY AND COMMUNITY GUIDELINES When you engage with Vericel® social media channels and our content providers on social media, you also agree to abide by the following Community Guidelines (found here: https://bit.ly/3pg3UKQ), which apply in addition to Vericel's Privacy Policy or other legal notices specific to each social media channel. Please note that third-party social media channels also have access to information you share via social media. For more details, read LinkedIn's Privacy Policy here: https://bit.ly/3GF2r5Y. For additional information about privacy at Vericel, please see our Privacy Policy (bit.ly/43ErZcx) and Terms and Conditions of Use (bit.ly/4568Cdx). If you engage with us, you consent and give Vericel permission to communicate with you and to use any information, text and media associated with the interaction or post. NEXOBRID is a registered trademark of Vericel Corp.

View contact profiles from Vericel® Burn Care